Found 0 matching trials
Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes Mellitus
PHASE3To evaluate the similarity of the efficacy and safety of semaglutide inject...
Location
Sun Yat-sen Memorial Hospital, Sun Yat-sen University
A Research Study to Look at How Insulin 287 and Semaglutide Work in the Body of People With Type 2 Diabetes When Taken Alone or Together
PHASE1The study will look at how insulin 287 and semaglutide work in the body, bo...
Location
Profil Institut für Stoffwechselforschung GmbH
Efficacy of Once Weekly Semaglutide in Patients With Type 2 Diabetes: a Non Randomized Clinical Trial
PHASE4A single arm no randomized clinical trial evaluated the effectiveness and s...
Location
Rehman Medical Institute
Beta Cell Function in Type 2 Diabetes: Differential Effects of SGLT2 Inhibitors and GLIP-Receptor Agonists
PHASE4Minorities have higher rates of diabetes, poorer glucose control, and highe...
Status
Active Not Recruiting
Location
SUNY Downstate Health Sciences University
Treatment to Regress to Normoglycemia in Women with a Recent History of GDM
PHASE4The purpose of the study is to determine the efficacy of semaglutide 1mg (O...
Effect of Semaglutide on Healing of Foot Ulcers in Type 2 Diabetes Patients
PHASE3The aim of this exploratory pilot study is to investigate the effect of sem...
Location
Copenhagen Wound Healing Center, Bispebjerg University Hospital
Post-Marketing Surveillance (Special Use-results Surveillance) on Long-term Use With OzempicĀ®
N/AThe purpose of this study is to assess the safety of long-term treatment wi...
Location
Seino Internal Medicine Clinic_Internal medicine
Weekly Subcutaneous Semaglutide as Adjunct to Closed-loop Therapy in Type 1 Diabetes Care
PHASE2A closed-loop insulin system, also referred to as the "artificial pancreas"...
Location
Research Institute of the McGill University Health Centre
Impact of Semaglutide (Ozempic/WegovyĀ®) on Heart and Muscle Mass
N/AThe aim of this study is to use advanced MRI scans to track changes in both...
Location
Mazankowski Alberta Heart Institute
Alleviating Carbohydrate Counting for Patients with Type-1 Diabetes Using a Closed Loop System with Weekly Subcutaneous Semaglutide
PHASE2A closed-loop insulin system, often labelled the "artificial pancreas" (AP)...
Location
Research Institute of the McGill University Health Centre